Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity vasculitis induced by cefoperazone/sulbactam.

Ismail Islek1, Sancar Baris, Ali O Katranci

  • 1Department of Pediatrics, Ondokuz Mayis University, School of Medicine, Samsun, Turkey. iislek@omu.edu.tr

Annals of Clinical Microbiology and Antimicrobials
|January 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nephrotic syndrome following hepatitis B vaccination: A 17-year follow-up.

Northern clinics of Istanbul·2021
Same author

Histopathological and mechanical effects of Ankaferd Blood Stopper® on wound healing in rats: an experimental model

Turkish journal of medical sciences·2020
Same author

Isolated tubal torsion: A rare cause of acute abdomen in childhood.

Pediatric reports·2018
Same author

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.

The Pan African medical journal·2018
Same author

Urine analysis of the 20th century Ottoman royal palace members and their interpretation: samples from 'Prime ministry Ottoman archives.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2018
Same author

Henoch-Schonlein purpura associated with primary active Epstein-Barr virus infection: a case report.

The Pan African medical journal·2017
Same journal

Clinical characteristics and temporal trends of meropenem and piperacillin/tazobactam heteroresistance in Pseudomonas aeruginosa isolates.

Annals of clinical microbiology and antimicrobials·2026
Same journal

Investigation of atypical microbial agents in patients with sterile pyuria.

Annals of clinical microbiology and antimicrobials·2026
Same journal

Convergent evolution of ST2 and ST164 mediates dissemination of the bla<sub>NDM-1</sub>/bla<sub>OXA-23</sub> profile in Acinetobacter baumannii.

Annals of clinical microbiology and antimicrobials·2026
Same journal

Efficacy and safety of intravenous combined with aerosolized colistimethate sodium for carbapenem-resistant organism-induced pneumonia: a retrospective study.

Annals of clinical microbiology and antimicrobials·2026
Same journal

A longitudinal analysis of Clostridioides difficile virulence profiles across three geographic regions in Israel (2020-2022).

Annals of clinical microbiology and antimicrobials·2026
Same journal

Associations of Mycoplasma pneumoniae load, co-infections, and macrolide resistance with clinical-laboratory profiles in hospitalized pediatric pneumonia: a targeted next-generation sequencing study of bronchoalveolar lavage fluid.

Annals of clinical microbiology and antimicrobials·2026
See all related articles

This case study reports the first instance of hypersensitivity vasculitis linked to cefoperazone/sulbactam. The condition resolved after discontinuing the antibiotic, suggesting a causal relationship.

Area of Science:

  • Pharmacology
  • Immunology
  • Clinical Medicine

Background:

  • Cefoperazone/sulbactam is an antibiotic commonly used for bacterial infections.
  • Vasculitic complications have not been previously associated with cefoperazone.
  • Hypersensitivity vasculitis is an inflammatory condition affecting blood vessels.

Purpose of the Study:

  • To report a rare case of hypersensitivity vasculitis.
  • To investigate the potential link between cefoperazone/sulbactam and vasculitis.

Main Methods:

  • A case presentation of a 13-year-old female patient with appendicitis.
  • Administration of cefoperazone/sulbactam for treatment.
  • Observation of clinical symptoms and disease progression.
  • Discontinuation of cefoperazone/sulbactam and monitoring for resolution.

Related Experiment Videos

Main Results:

  • The patient developed symptoms of hypersensitivity vasculitis on the fifth day of antibiotic therapy.
  • Vasculitis symptoms gradually resolved after cefoperazone/sulbactam was discontinued on the seventh day.
  • No recurrence of vasculitis was observed after drug removal.

Conclusions:

  • This is the first reported case of hypersensitivity vasculitis associated with cefoperazone/sulbactam.
  • The findings suggest a potential causal relationship between cefoperazone/sulbactam and hypersensitivity vasculitis.
  • Further investigation may be warranted to understand this adverse drug reaction.